image
Energy - Oil & Gas Equipment & Services - NYSE - NL
$ 19.53
-2.11 %
$ 917 M
Market Cap
36.17
P/E
1. INTRINSIC VALUE

Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, and production.[ Read More ]

The intrinsic value of one CLB stock under the base case scenario is HIDDEN Compared to the current market price of 19.5 USD, Core Laboratories N.V. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart CLB

image
FINANCIALS
510 M REVENUE
4.10%
54.6 M OPERATING INCOME
31.59%
37 M NET INCOME
88.35%
24.8 M OPERATING CASH FLOW
-0.67%
-6.65 M INVESTING CASH FLOW
-72.51%
-18.4 M FINANCING CASH FLOW
21.09%
134 M REVENUE
2.93%
19.8 M OPERATING INCOME
45.42%
11.7 M NET INCOME
30.04%
13.1 M OPERATING CASH FLOW
-23.21%
-530 K INVESTING CASH FLOW
21.79%
-9.18 M FINANCING CASH FLOW
32.56%
Balance Sheet Decomposition Core Laboratories N.V.
image
Current Assets 223 M
Cash & Short-Term Investments 15.1 M
Receivables 123 M
Other Current Assets 84.9 M
Non-Current Assets 363 M
Long-Term Investments 4.84 M
PP&E 153 M
Other Non-Current Assets 205 M
Current Liabilities 88.1 M
Accounts Payable 33.5 M
Short-Term Debt 10.2 M
Other Current Liabilities 44.4 M
Non-Current Liabilities 268 M
Long-Term Debt 205 M
Other Non-Current Liabilities 63.3 M
EFFICIENCY
Earnings Waterfall Core Laboratories N.V.
image
Revenue 510 M
Cost Of Revenue 416 M
Gross Profit 94 M
Operating Expenses 40.3 M
Operating Income 54.6 M
Other Expenses 17.6 M
Net Income 37 M
RATIOS
18.45% GROSS MARGIN
18.45%
10.72% OPERATING MARGIN
10.72%
7.19% NET MARGIN
7.19%
16.31% ROE
16.31%
6.25% ROA
6.25%
12.65% ROIC
12.65%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Core Laboratories N.V.
image
Net Income 37 M
Depreciation & Amortization 15.8 M
Capital Expenditures -10.6 M
Stock-Based Compensation 14 M
Change in Working Capital -28.8 M
Others -2.71 M
Free Cash Flow 14.2 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Core Laboratories N.V.
image
Wall Street analysts predict an average 1-year price target for CLB of $23 , with forecasts ranging from a low of $17 to a high of $32 .
CLB Lowest Price Target Wall Street Target
17 USD -12.95%
CLB Average Price Target Wall Street Target
23 USD 17.77%
CLB Highest Price Target Wall Street Target
32 USD 63.85%
4. DIVIDEND ANALYSIS
0.05% DIVIDEND YIELD
0.01 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership Core Laboratories N.V.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
4 years ago
Apr 01, 2020
Bought 2.78 K USD
GOLDMAN SACHS GROUP INC
10 percent owner
+ 300
9.25 USD
4 years ago
Apr 01, 2020
Bought 3.54 K USD
GOLDMAN SACHS GROUP INC
10 percent owner
+ 376
9.41 USD
4 years ago
Apr 01, 2020
Sell 0 USD
GOLDMAN SACHS GROUP INC
10 percent owner
- 1176
0 USD
4 years ago
Apr 01, 2020
Bought 0 USD
GOLDMAN SACHS GROUP INC
10 percent owner
+ 93
0 USD
4 years ago
May 07, 2020
Bought 10.2 K USD
Sodderland Jan Willem
Director
+ 600
17.07 USD
4 years ago
Feb 03, 2020
Bought 34.6 K USD
Bruno Lawrence
President & COO
+ 1000
34.6 USD
4 years ago
Feb 03, 2020
Bought 35 K USD
Bruno Lawrence
President & COO
+ 1000
34.979 USD
4 years ago
Feb 03, 2020
Bought 35 K USD
Bruno Lawrence
President & COO
+ 1000
35 USD
4 years ago
Jan 02, 2020
Sell 3.79 K USD
Elvig Mark F
VP,Counsel & Secretary
- 100
37.94 USD
4 years ago
Jan 02, 2020
Sell 19 K USD
Elvig Mark F
VP,Counsel & Secretary
- 500
37.93 USD
5 years ago
Aug 14, 2019
Bought 76 K USD
Barnett Gregory Barry
Director
+ 2000
38 USD
5 years ago
Aug 13, 2019
Bought 40 K USD
Barnett Gregory Barry
Director
+ 1000
40 USD
5 years ago
Mar 11, 2019
Sell 28.4 K USD
Daniels Kevin
CAO & Treasurer
- 428
66.25 USD
6 years ago
Oct 29, 2018
Bought 17.2 K USD
Sodderland Jan Willem
Director
+ 200
85.76 USD
6 years ago
Aug 14, 2018
Sell 8.22 K USD
Daniels Kevin
CAO & Treasurer
- 73
112.63 USD
7 years ago
Feb 01, 2017
Bought 12.6 K USD
Straughen Michael
Director
+ 106
118.65 USD
7 years ago
Jan 30, 2017
Bought 23 K USD
Carnes Martha Z.
Director
+ 200
115.2 USD
8 years ago
Feb 02, 2016
Bought 28.2 K USD
Sodderland Jan Willem
Director
+ 300
93.9 USD
9 years ago
Jul 24, 2015
Bought 31.9 K USD
Sodderland Jan Willem
Director
+ 300
106.2 USD
9 years ago
May 12, 2015
Sell 129 K USD
KEARNEY MICHAEL C
Director
- 1000
128.52 USD
7. News
Is the Options Market Predicting a Spike in CORE LABS INC (CLB) Stock? Investors need to pay close attention to CORE LABS INC (CLB) stock based on the movements in the options market lately. zacks.com - 1 week ago
Core Laboratories Inc. (CLB) Q3 2024 Earnings Call Transcript Core Laboratories Inc. (NYSE:CLB ) Q3 2024 Earnings Conference Call October 24, 2024 8:30 AM ET Company Participants Larry Bruno - Chairman and Chief Executive Officer Chris Hill - Chief Financial Officer Gwen Gresham - Senior Vice President and Head, Investor Relations Conference Call Participants Sean Mitchell - Daniel Energy Partners Stephen Gengaro - Stifel Operator Good day and welcome to the Core Lab Q3 2024 Earnings Conference Call. All participants will be in a listen-only mode. seekingalpha.com - 3 weeks ago
Core Laboratories' Q3 Earnings and Sales Beat Estimates CLB expects Reservoir Description revenues of $87.5-$90.5 million and Production Enhancement revenues of $41-$45 million for the fourth quarter of 2024. zacks.com - 3 weeks ago
Core Laboratories (CLB) Q3 Earnings Match Estimates Core Laboratories (CLB) came out with quarterly earnings of $0.25 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.22 per share a year ago. zacks.com - 3 weeks ago
CORE LAB REPORTS THIRD QUARTER 2024 RESULTS THIRD QUARTER REVENUE OF $134.4 MILLION, UP 3% SEQUENTIALLY AND OVER 7% YEAR-OVER-YEAR THIRD QUARTER OPERATING INCOME OF $19.8 MILLION; EX-ITEMS, $18.2 MILLION, UP 11% SEQUENTIALLY AND 14% YEAR-OVER-YEAR THIRD QUARTER OPERATING MARGINS, EX-ITEMS, OF 14% UP 100 BPS SEQUENTIALLY THIRD QUARTER GAAP EPS OF $0.25; EX-ITEMS, $0.25, UP 14% SEQUENTIALLY AND YEAR-OVER-YEAR THIRD QUARTER FREE CASH FLOW OF $10.4 MILLION NET DEBT REDUCED BY $11.8 MILLION; DEBT LEVERAGE RATIO REDUCED TO 1.47 COMPANY ANNOUNCES Q4 2024 QUARTERLY DIVIDEND HOUSTON , Oct. 23, 2024 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported third quarter 2024 revenue of $134,400,000. Core's operating income was $19,800,000, with diluted earnings per share ("EPS") of $0.25, all in accordance with U.S. generally accepted accounting principles ("GAAP"). prnewswire.com - 3 weeks ago
Energy Stocks to Watch Amid Q3 Earnings Despite Pricing Pressures Energy stocks such as PUMP, CLB and OII are poised to deliver a Q3 earnings beat. zacks.com - 3 weeks ago
What's in Store for Core Laboratories Stock in Q3 Earnings? CLB is expected to report higher revenues compared with the previous quarter, along with reduced costs for services and product sales and general administrative expenses. zacks.com - 1 month ago
Can Core Laboratories (CLB) Keep the Earnings Surprise Streak Alive? Core Laboratories (CLB) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. zacks.com - 1 month ago
Core Laboratories (CLB) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Core Laboratories (CLB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com - 1 month ago
Here's Why Core Laboratories (CLB) is a Strong Value Stock The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. zacks.com - 1 month ago
Equinor Strengthens Offshore Wind Portfolio With 9.8% Stake in Orsted EQNR secures a 9.8% stake in Orsted, becoming the latter's second-largest shareholder and advancing its commitment to offshore wind and renewable energy growth. zacks.com - 1 month ago
3 Energy Stocks to Buy on Continued Geopolitical Turmoil Buy energy stocks like Sasol (SSL), Core Lab (CLB) and Nine Energy (NINE) for steady returns in a volatile macroeconomic environment. zacks.com - 1 month ago
8. Profile Summary

Core Laboratories N.V. CLB

image
COUNTRY NL
INDUSTRY Oil & Gas Equipment & Services
MARKET CAP $ 917 M
Dividend Yield 0.05%
Description Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. In addition, the company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. It operates approximately in 50 countries. The company was founded in 1936 and is based in Amstelveen, the Netherlands.
Contact Van Heuven Goedhartlaan 7 B, Amstelveen, 1181 LE https://www.corelab.com
IPO Date Sept. 21, 1995
Employees 3500
Officers Mr. Lawrence V. Bruno Chairman of the Board, Chief Executive Officer, President & Chief Operating Officer Mr. Sow Hang Teo Vice President, Treasurer & Chief Accounting Officer Mr. Jacobus Schouten Managing Director Mr. Mark Damian Tattoli Senior Vice President, Secretary & General Counsel J. Donald Dumas Jr. Senior Vice President of Production Enhancement & Business Development Leslie Linklater Vice President People, Organization, & Culture Ms. Gwendolyn Y. Gresham M.B.A. Senior Vice President of Corporate Development & Investor Relations Mr. Christopher Scott Hill Senior Vice President & Chief Financial Officer